SCHEMBL287131

SCHEMBL287131

Cc1ccc(S(=O)(=O)NNC(=O)C2=CN(CC(=O)Nc3ccccc3)C=CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
HPGD P15428 3/20 0.48
LMNA P02545 4/20 0.46
POLB P06746 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
GAA P10253 4/20 0.44
KDM4E B2RXH2 3/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 2/20 0.43
GFER P55789 2/20 0.42
KCNA5 P22460 1/20 0.42
KCNH2 Q12809 1/20 0.42
KMT2A Q03164 2/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL287496 0.93 KAT6A (0.44) ALDH1A1GAAHTTKMT2AMEN1
SCHEMBL658736 0.90 NPSR1 (0.46) ALDH1A1HPGDLMNAPOLBTDP1
SCHEMBL658510 0.86 POLB (0.47) ALDH1A1HPGDLMNAPOLBTDP1
SCHEMBL286819 0.82 MAPT (0.43) ALDH1A1LMNAPOLBGAAKDM4E
SCHEMBL287827 0.80 ALDH1A1 (0.41) ALDH1A1LMNAGAAKDM4EHTT
SCHEMBL660454 0.79 KAT6A (0.51) ALDH1A1GAAKMT2ACYP3A4MEN1
SCHEMBL287138 0.77 GFER (0.52) ALDH1A1LMNAGAAKDM4EL3MBTL1
SCHEMBL660141 0.76 HTT (0.53) ALDH1A1GAAKDM4EHTTGFER
SCHEMBL660292 0.74 ALDH1A1 (0.43) ALDH1A1LMNAKDM4EHTTKMT2A
SCHEMBL660129 0.74 GAA (0.46) ALDH1A1LMNAGAAKMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427432-A2 NOVEL HETEROCYCLIC COMPOUNDS Torrent Pharmaceuticals Limited (IN) 2012-03-14 EP claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT ALDH1A1 676/4885HPGD 202/4885LMNA 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.